Diabetes Therapy
Benfluorex in combination with sulfonylurea was beneficial for type 2 diabetics
Published in Diabetes Week, April 24th, 2006
According to recent research from France, "The aim of this study was to demonstrate the superiority of benfluorex over placebo as an add-on therapy in type 2 diabetic patients in whom diabetes is insufficiently controlled by sulfonylurea monotherapy and who have a limitation for the use of metformin."
P. Moulin and colleagues working with Hopital Cardio-Vasculaire Louis Pradel explained, "Type 2 diabetic patients with HbA1C (A1C) ID (7-10%) who were receiving the maximum tolerated sulfonylurea...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2006-04-24)
More Articles from Diabetes Week
- Diabetes Epidemiology
Amino acid variants in activating transcription factor 6 gene linked to type 2 diabetes - Diabetes Pathogenesis
Chaperonin 60 may indicate mitochondrial dysfunction in diabetic central nervous system - Diabetes Pathogenesis
Increased pp38MAPK and pHSP25 comprise acute adaptation to glycemic stress in diabetes - Diabetes Therapy
Glucose-dependent insulinotropic peptides are long-acting stable analogues for diabetes therapy - Diabetic Nephropathy
Diabetic nephropathy diagnosis allows identification of patients with high cardiorenal risk - Alzheimer Disease
Increased cortical atrophy in type 2 diabetes mellitus may increase Alzheimer disease risk - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
